Testing antibiotic doses in older adults in the emergency room
Treatments studied
Part of Infections clinical trials.
This study looks at how best to dose certain antibiotics in people age 75 and older who are admitted to a geriatric (older-adult) hospital unit. It aims to measure antibiotic levels in the body to see whether dosing can be improved for older patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 75 or older and you come to the emergency department
- After the emergency visit, you are admitted to the geriatric department (not ICU or another unit)
- You have an “older adult health” screening score that meets their geriatric criteria (KATZ, G8, or CIRS)
- You are being treated with one of these antibiotics: amoxicillin-clavulanate or piperacillin-tazobactam
- You can have blood tests using an IV line, and they need an IV line separate from the antibiotic drip line for one measurement
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether older adults (75+) who come to the emergency department have problems with their medications. A clinical pharmacist will check your medicines to see if any changes are needed to help you feel better and avoid side effects.
This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.
This trial tests a personalized dosing approach for certain antibiotics (amoxicillin-clavulanic acid, piperacillin-tazobactam, and meropenem) in hospitalized children with serious infections. The goal is to adjust the dose based on blood tests to make sure each child gets the right amount of medicine.
This study tests a computer tool that helps doctors give the right dose of strong antibiotics to ICU patients. It is for adults who have recently started one of two specific antibiotics.
This trial tests whether elderly patients hospitalized with a viral lower respiratory infection can safely stop antibiotics early. It aims to reduce unnecessary antibiotic use and side effects.
This trial checks if giving higher doses of beta-lactam antibiotics (a type of strong antibiotic) right from the start helps people in the ICU with septic shock. It aims to find the best dose to fight the infection quickly.
Hear when a new Elderly Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.